Tags : ~$550M

M&A MedTech

Allergan Aesthetics to Acquire Soliton and its Resonic Device for

Shots: Soliton to receive $22.60 /share in cash for its all outstanding share making the total deal value $550M The acquisition adds Soliton’s Rapid Acoustic Pulse technology platform to Allergan Aesthetics’s portfolio for improvement in appearance of cellulite in the buttocks and thighs by using rapid high-frequency sound waves to disrupt targeted cellular structures and […]Read More


Lilly Signs a Global Research and License Collaboration with Dicerna

Shots: Dicerna will receive $100M upfront plus ~$350M as development and commercialization milestones with tiered royalties and equity investment of $100M Lilly will get hold of Dicerna’s GalXC RNAi technology as well as development and commercialization rights to new developed drugs in fields of cardio-metabolic diseases, neurodegeneration and pain Dicerna’s GalXC RNAi technology is an […]Read More